|
|
News & Comments |
|
177 |
|
|
|
|
|
Editorial |
| Combined strategies for gene therapy of AIDS |
179 |
| Giorgio Palù
|
|
Full Article (PDF)
|
|
Papers |
| Immune-mediated destruction of transfected muscle fibers after direct gene transfer with antigen-expressing plasmid DNA |
181 |
| HL Davis,
CL Brazolot Millan & SC Watkins
|
|
Abstract
Full Article (PDF)
|
|
| Improved efficiency of arterial gene transfer by use of poloxamer 407 as a vehicle for adenoviral vectors |
189 |
| LJ Feldman,
CJ Pastore,
N Aubailly,
M Kearney,
D Chen,
M Perricaudet,
PG Steg & JM Isner
|
|
Abstract
Full Article (PDF)
|
|
| A placebo-controlled study of liposome-mediated gene transfer to the nasal epithelium of patients with cystic fibrosis |
199 |
| DR Gill,
KW Southern,
KA Mofford,
T Seddon,
L Huang,
F Sorgi,
A Thomson,
LJ MacVinish,
R Ratcliff,
D Bilton,
DJ Lane,
JM Littlewood,
AK Webb,
PG Middleton,
WH Colledge,
AW Cuthbert,
MJ Evans,
CF Higgins & SC Hyde
|
|
Abstract
Full Article (PDF)
|
|
| Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis |
210 |
| DJ Porteous,
JR Dorin,
G McLachlan,
H Davidson-Smith,
H Davidson,
BJ Stevenson,
AD Carothers,
WAH Wallace,
S Moralee,
C Hoenes,
G Kallmeyer,
U Michaelis,
K Naujoks,
L-P Ho,
JM Samways,
M Imrie,
AP Greening & JA Innes
|
|
Abstract
Full Article (PDF)
|
|
| Use of SV40-based vectors to transduce foreign genes to normal human peripheral blood mononuclear cells |
219 |
| DS Strayer,
R Kondo,
J Milano & L-X Duan
|
|
Abstract
Full Article (PDF)
|
|
| Characterization of liposome-mediated gene delivery: expression, stability and pharmacokinetics of plasmid DNA |
226 |
| AR Thierry,
P Rabinovich,
B Peng,
LC Mahan,
JL Bryant & RC Gallo
|
|
Abstract
Full Article (PDF)
|
|
| Safety studies of the intraperitoneal injection of E1A-liposome complex in mice |
238 |
| X Xing,
V Liu,
W Xia,
LC Stephens,
L Huang,
G Lopez-Berestein & M-C Hung
|
|
Abstract
Full Article (PDF)
|
|
| Mechanism of ‘bystander effect’ killing in the herpes simplex thymidine kinase gene therapy model of cancer treatment |
244 |
| H Ishii-Morita,
R Agbaria,
CA Mullen,
H Hirano,
DA Koeplin,
Z Ram,
EH Oldfield,
DG Johns & RM Blaese
|
|
Abstract
Full Article (PDF)
|
|
| Constitutive systemic expression of IL-1Ra or soluble TNF receptor by genetically modified hematopoietic cells suppresses LPS induction of IL-6 and IL-10 |
252 |
| LA Doughty,
KD Patrene,
CH Evans,
SS Boggs & PD Robbins
|
|
Abstract
Full Article (PDF)
|
|
| Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy |
258 |
| A Amalfitano & JS Chamberlain
|
|
Abstract
Full Article (PDF)
|
|
Brief Communications |
| A strategy for specific targeting of therapeutic agents to tumour cells of virus-associated cancers |
264 |
| TJ Evans,
L Brooks & PJ Farrell
|
|
Abstract
Full Article (PDF)
|
|
| Human CD34+ cells do not express glutathione S-transferases alpha |
268 |
| M Czerwinski,
H-P Kiem & JT Slattery
|
|
Abstract
Full Article (PDF)
|
|